A metagenomic study of the gut microbiome in Behcet's disease - PubMed (original) (raw)
doi: 10.1186/s40168-018-0520-6.
Ni Zhang 1, Chunyan Wu 2, Xinyuan Zhang 3, Qingfeng Wang 1, Xinyue Huang 1, Liping Du 1, Qingfeng Cao 1, Jihong Tang 1, Chunjiang Zhou 1, Shengping Hou 1, Yue He 1, Qian Xu 2 4, Xiao Xiong 2, Aize Kijlstra 5, Nan Qin 2 6, Peizeng Yang 7
Affiliations
- PMID: 30077182
- PMCID: PMC6091101
- DOI: 10.1186/s40168-018-0520-6
A metagenomic study of the gut microbiome in Behcet's disease
Zi Ye et al. Microbiome. 2018.
Abstract
Background: Behcet's disease (BD) is a recalcitrant, multisystemic inflammatory disease that can lead to irreversible blindness. Microbial agents have been considered to contribute to the pathogenesis of this disease, but the underlying mechanisms remain unclear. In this study, we investigated the association of gut microbiome composition with BD as well as its possible roles in the development of this disease.
Methods: Fecal and saliva samples were collected from 32 active BD patients and 74 healthy controls. DNA extracted from fecal samples was subjected to metagenomic analysis, whereas DNA extracted from saliva samples was subjected to 16S rRNA gene sequencing analysis. The results were used to compare the composition and biological function of the microbiome between patients and healthy controls. Lastly, transplantation of pooled fecal samples from active BD patients into B10RIII mice undergoing experimental autoimmune uveitis (EAU) was performed to determine the causal relationship between the gut microbiome and BD.
Results: Fecal samples from active BD patients were shown to be enriched in Bilophila spp., a sulfate-reducing bacteria (SRB) and several opportunistic pathogens (e.g., Parabacteroides spp. and Paraprevotella spp.) along with a lower level of butyrate-producing bacteria (BPB) Clostridium spp. and methanogens (Methanoculleus spp. Methanomethylophilus spp.). Analysis of microbial functions revealed that capsular polysaccharide transport system, oxidation-reduction process, type III, and type IV secretion systems were also increased in active BD patients. Network analysis showed that the BD-enriched SRB and opportunistic pathogens were positively correlated with each other, but they were negatively associated with the BPB and methanogens. Animal experiments revealed that fecal microbiota transplantation with feces from BD patients significantly exacerbated EAU activity and increased the production of inflammatory cytokines including IL-17 and IFN-γ.
Conclusions: Our findings revealed that BD is associated with considerable gut microbiome changes, which is corroborated by a mouse study of fecal microbiota transplants. A model explaining the association of the gut microbiome composition with BD pathogenesis is proposed.
Keywords: Behcet’s disease; Fecal microbiota transplant; Gut microbiome; Metagenomic analysis.
Conflict of interest statement
All procedures followed the tenets of the Declaration of Helsinki and were approved by the Ethics Committee of Chongqing Medical University with written informed consent.
We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, there is no professional or other personal interest of any nature or kind in any product, service, and/or company that could be construed as influencing the position presented in, or the review of, the manuscript entitled, “A metagenomic study of the gut microbiome in Behcet’s disease”.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Fig. 1
Phyla (a), genera (b), and species (c) showing significant differences in fecal metagenome profiles when comparing BD patients with healthy controls. Differentially abundant phylotypes were identified by Wilcoxon rank sum test (FDR < 0.1, corrected by the Benjamini and Hochberg for multiple comparisons). Only the top 5 phyla and top 10 genera are shown. The phylotypes enriched in healthy group are colored red. The relative abundance was shown by boxplot. Boxes represent the inter quartile ranges, lines inside the boxes denote medians, and ‘+’ denotes means
Fig. 2
Linear discrimination analysis (LDA) effect size (LEfSe) analysis results comparing the BD and healthy groups. a Histogram of the LDA scores computed for genera differentially abundant between BD subjects and healthy controls. The LDA scores (log10) > 2 are listed. b SparCC network plot of co-abundance and co-exclusion correlations between differentially abundant SRB, BPB, methanogens, and opportunistic pathogens. Each node represents one species, and two nodes are linked if the correlation was significant (two-sided pseudo p ≤ 0.1 based on bootstrapping of 100 repetitions). Lines between nodes show positive correlations (solid lines) or negative correlations (dashed lines). The node size is proportional to the mean relative abundance of species in the enriched population. Nodes were colored as follows: orange, sulfate-reducing bacteria; purple, lactate-producing bacteria; blue, butyrate-producing bacteria; green, methanogens
Fig. 3
MGSs analysis. a The heatmap of 25 ‘tracer’ genes abundance for each MGS were shown. Individuals are represented along the horizontal axis. Abundance of genes in rows is indicated by color gradient (white, not detected), and the enrichment significance is shown on the right with P value by Wilcoxon test. b The relative importance of each MGS in the predictive random forest model using the mean decreasing accuracy. c Relationship between the numbers of MGSs included in random forest model and the corresponding predictive performance (estimated by 10-fold cross-validation). d The ROC curve for the random forest model using 13 MGSs
Fig. 4
Effect of transplantation of feces from BD patients on EAU. Pooled feces from active BD patients transferred to B10RIII mice by oral gavage. Pooled feces from healthy individuals and PBS were transferred to mice as control groups. EAU was induced by immunization with IRBP161–180. On day 14 after EAU induction, clinical and histological scores of BD patients’ feces-treated group (a and d), healthy’ feces-treated group (b and e), and PBS-treated group (c and f) were determined. Combined data in (g) for clinical score and (h) for histological score. Each point represents an individual eye. The horizontal bars denote the average scores of each group. The spleens were also removed from EAU mice on day 14 after induction. IFN-γ (i) and IL-17 (j) mRNA levels were evaluated by real-time PCR
Fig. 5
Chart of possible mechanisms explaining the relation between gut microbiome composition and development of Behcet’s disease. a Dysbiosis of the gut microbiome might be caused via dietary intake in individuals carrying the susceptibility genes for BD. The dysbiosis of the gut microbiome in BD is characterized by enriched sulfate-reducing bacteria (SRB) and some opportunistic pathogens in association with depleted butyrate-producing bacteria (BPB) and methanogens. b Gut metabolism in BD shows an overwhelming presence of H2S and shortage of butyrate and methane. This abnormal environment can contribute to the intestinal epithelial barrier damage and facilitate effector molecules or pathogen-associated molecular pattern (PAMP) to invade the intestinal epithelial cells (IEC). c The PAMPs including PNG/LPS combine with their corresponding pattern recognition receptors (PRR) TLR2/TLR4 on IEC. This process leads to chronic inflammation involving hyperactivation of T helper 1 (TH1) and T helper 17 (TH17) cells in the gut. d The effector molecules or PAMP migrate to blood vessels through the hepatic circulation. Then, they recognize the receptors of TLR/TLR4 on vascular endothelial cells (VEC) and induce systemic vasculitis via the subsequent activation of TH1 and TH17 cells. e A damaged vascular endothelial barrier due to the systemic vasculitis. The effector molecules or PAMP can further migrate to organs or tissues such as the eye, joint, skin, oral, and genital mucosa though the damaged vascular endothelial barrier. Subsequently, the PAMP recognize the receptors TLR2/TLR4 in these organs or tissues, which result in various clinical manifestations of BD, such as uveitis, arthritis, skin lesions, oral, or genital ulcers. f Since oral ulcers (aphthosis) can be induced by both disturbances of the oral microbiome and dysbiosis of the gut microbiome, it presents as the most common clinical feature in BD
Similar articles
- Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behçet's disease.
Coit P, Mumcu G, Ture-Ozdemir F, Unal AU, Alpar U, Bostanci N, Ergun T, Direskeneli H, Sawalha AH. Coit P, et al. Clin Immunol. 2016 Aug;169:28-35. doi: 10.1016/j.clim.2016.06.002. Epub 2016 Jun 7. Clin Immunol. 2016. PMID: 27283393 - Eubacterium rectale Attenuates HSV-1 Induced Systemic Inflammation in Mice by Inhibiting CD83.
Islam SMS, Ryu HM, Sayeed HM, Byun HO, Jung JY, Kim HA, Suh CH, Sohn S. Islam SMS, et al. Front Immunol. 2021 Aug 31;12:712312. doi: 10.3389/fimmu.2021.712312. eCollection 2021. Front Immunol. 2021. PMID: 34531862 Free PMC article. - The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
Abdelbary MMH, Hatting M, Bott A, Dahlhausen A, Keller D, Trautwein C, Conrads G. Abdelbary MMH, et al. Front Cell Infect Microbiol. 2022 Oct 7;12:1010853. doi: 10.3389/fcimb.2022.1010853. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36275026 Free PMC article. - Microbiome and Behçet's disease: a systematic review.
Joubert M, André M, Barnich N, Billard E. Joubert M, et al. Clin Exp Rheumatol. 2023 Oct;41(10):2093-2104. doi: 10.55563/clinexprheumatol/zbt4gx. Epub 2023 Jun 7. Clin Exp Rheumatol. 2023. PMID: 37382445 Review. - Gut Microbiota Profile in Patients with Type 1 Diabetes Based on 16S rRNA Gene Sequencing: A Systematic Review.
Zhou H, Zhao X, Sun L, Liu Y, Lv Y, Gang X, Wang G. Zhou H, et al. Dis Markers. 2020 Aug 27;2020:3936247. doi: 10.1155/2020/3936247. eCollection 2020. Dis Markers. 2020. PMID: 32908614 Free PMC article. Review.
Cited by
- The Relationship Between Gut Microbiome and Ophthalmologic Diseases: A Comprehensive Review.
Lima Barrientos J, Rojas Huerta A, Perez Mendoza A, Abreu Lopez BA, Salolin Vargas VP, Garcia Gonzalez OY, Saldaña Ruiz MA, Diarte E, Torijano Sarria AJ. Lima Barrientos J, et al. Cureus. 2024 Aug 13;16(8):e66808. doi: 10.7759/cureus.66808. eCollection 2024 Aug. Cureus. 2024. PMID: 39280427 Free PMC article. Review. - A two sample mendelian randomization analysis investigates causal effects between gut microbiome and immune related Vasculitis.
Chen S, Nie R, Wang C, Luan H, Ma X, Gui Y, Zeng X, Yuan H. Chen S, et al. Sci Rep. 2024 Aug 13;14(1):18810. doi: 10.1038/s41598-024-68205-0. Sci Rep. 2024. PMID: 39138194 Free PMC article. - A novel Bacillus aerolatus CX253 attenuates inflammation induced by Streptococcus pneumoniae in childhood and pregnant rats by regulating gut microbiome.
Yu T, Wu B, Zhang D, Deng G, Luo Y, Tang N, Shi Q, Hu F, Zhang G. Yu T, et al. Cell Mol Life Sci. 2024 Jul 29;81(1):319. doi: 10.1007/s00018-024-05232-0. Cell Mol Life Sci. 2024. PMID: 39078497 Free PMC article. - Decoding Behcet's Uveitis: an In-depth review of pathogenesis and therapeutic advances.
Guan Y, Li F, Li N, Yang P. Guan Y, et al. J Neuroinflammation. 2024 May 22;21(1):133. doi: 10.1186/s12974-024-03123-6. J Neuroinflammation. 2024. PMID: 38778397 Free PMC article. Review. - What we need to know about the germ-free animal models.
Aghighi F, Salami M. Aghighi F, et al. AIMS Microbiol. 2024 Feb 6;10(1):107-147. doi: 10.3934/microbiol.2024007. eCollection 2024. AIMS Microbiol. 2024. PMID: 38525038 Free PMC article. Review.
References
- Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57:289–300.
- Berer K, Gerdes LA, Cekanaviciute E, Jia X, Xiao L, Xia Z, Liu C, Klotz L, Stauffer U, Baranzini SE, et al. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc Natl Acad Sci U S A. 2017;114:10719–10724. doi: 10.1073/pnas.1711233114. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous